People: Actavis PLC (ACT)

ACT on New York Consolidated

241.81USD
19 Sep 2014
Price Change (% chg)

$3.88 (+1.63%)
Prev Close
$237.93
Open
$239.49
Day's High
$245.50
Day's Low
$236.41
Volume
3,676,989
Avg. Vol
2,305,152
52-wk High
$245.50
52-wk Low
$135.50

Search Stocks

Michal, Jiri 

Brief Biography

Mr. Jiri Michal is Independent Director of Actavis PLC. Mr. Michal most recently served as Chairman of the Board and Chief Executive Officer of Zentiva until 2010. During his 36-year involvement with the company, which included 20 years as CEO, Mr. Michal held numerous positions and directed the growth of the company through several acquisitions, initiated modernization and privatization and lead a successful management buy-out, culminating in a successful initial public offering in 2004. In 2009, Zentiva became part of Sanofi Group. Mr. Michal was appointed Chairman of the Board of Prague Chemical University in 2011, and is an acting member of the Board of Directors of Moser in the Czech Republic.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Paul Bisaro

11,381,100

Brenton Saunders

--

Robert Stewart

5,216,480

David Buchen

2,845,440

James D'Arecca

--

Patrick Eagan

--
As Of 30 Dec 2013
Search Stocks